This was later confirmed by Hideshima and colleagues later who reported that BTZ promotes non-proteasomal degradation of IκB through activation of IKK and RIP2, leading to improved canonical NF-κB activity in both MM cell lines and primary cells [21]. Here, NFKB1 is linked to Miyoshi myopathy.